(*Co-first author; #Co-corresponding author)
1. Han C*, Godfrey V*, Liu Z, Han Y, Liu L, Peng H, Hasan Z#, Fu Y#. The AIM2 and NLRP3 inflammasomes trigger IL-1–mediated antitumor effects during radiation. Science immunology, 2021.
2. Han C*, Liu Z*,Zhang Y, Shen A, Dong C, Zhang A, Moor C, Cao X, Ren Z, Lu C, Qiao J#, Fu Y#. Tumor cells suppress radiation-induced immunity by hijacking caspase 9 signaling. Nature immunology, 2020.
3. Han C, Fu Y. β-catenin regulates tumor-derived PD-L1. Journal of Experimental Medicine, 2020.
4. Han C. Zhang A, Liu Z, C Moore. Fu Y#. Small molecular drugs reshape tumor microenvironment to synergize with immunotherapy. Oncogene, 2020.
5. Liu Z*, Han C*, Dong C, Shen A, Hsu E, Ren Z, Lu C, Liu L, Zhang A, Timmerman C, Pu Y, Wang Y, Chen M, Qiao J, Fu Y#. Hypofractionated EGFR tyrosine kinase inhibitor limits tumor relapse through triggering innate and adaptive immunity. Science immunology. 2019.
